Day One Biopharmaceuticals, Inc. (DAWN) reported Q4 Revenue ; Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

February 24, 2026 4:06 PM EST
Get Alerts DAWN Hot Sheet
Price: $21.53 --0%

Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) reported Q4 Revenue for the quarter came in at $52.8 million versus the consensus estimate of $45.86 million.

GUIDANCE:

Day One Biopharmaceuticals, Inc. sees FY2026 revenue of $225-250 million, versus the consensus of $236.6 million.

For earnings history and earnings-related data on Day One Biopharmaceuticals, Inc. (DAWN) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK